INTRODUCTION: Atherosclerotic carotid artery disease is responsible for a variety of clinical presentations, ranging from asymptomatic to cerebral ischemic events. Considering the upcoming use of noninvasive imaging modalities, plaque characteristics could serve as a marker in the selection of patients eligible for carotid endarterectomy (CEA). This would be more likely if characteristics corresponded with clinical manifestations and were predictive of future events. In this study, we hypothesized that plaque characteristics correlate with the clinical presentation of carotid artery disease. METHODS: We included 404 patients undergoing a carotid endarterectomy (CEA). Ipsilateral clinical symptoms and duplex measurements were recorded. Patients could be asymptomatic (23.5%) or symptomatic with stroke (26.5%), transient ischemic attack (TIA) (36.1%), or amaurosis fugax (AFX) (13.9%). Plaques were stained and semi-quantitatively analyzed for the presence of macrophages, smooth muscle cells, collagen, calcifications, and thrombus. Plaques were categorized in three phenotypes by their overall presentation and the amount of fat. In addition, plaque matrix metalloproteinase (MMP) activity and cytokines expressions were measured. RESULTS: Fibrous, fibro-atheromatous, and atheromatous plaques were observed in 30.2%, 35.6%, and 34.2%, respectively. Atheromatous plaques were more prevalent in patients with stroke and TIA compared with asymptomatic patients or patients with AFX (P = .001). Collagen staining was less evident in patients with TIA and stroke compared with asymptomatic patients or patients with AFX (P < .001). Plaques of patients with TIA and stroke showed significantly higher activity levels of MMP-8 and MMP-9 and higher levels of interleukin-8 compared with asymptomatic and AFX patients. CONCLUSION: Plaque phenotype of patients with TIA is comparable to that of patients with stroke; whereas, the plaque phenotype of patients with AFX resembles the plaque phenotype of asymptomatic patients. Follow-up studies should be encouraged to determine whether plaque characteristics visualized by imaging techniques might help to identify patients most likely to benefit from CEA.
INTRODUCTION:Atherosclerotic carotid artery disease is responsible for a variety of clinical presentations, ranging from asymptomatic to cerebral ischemic events. Considering the upcoming use of noninvasive imaging modalities, plaque characteristics could serve as a marker in the selection of patients eligible for carotid endarterectomy (CEA). This would be more likely if characteristics corresponded with clinical manifestations and were predictive of future events. In this study, we hypothesized that plaque characteristics correlate with the clinical presentation of carotid artery disease. METHODS: We included 404 patients undergoing a carotid endarterectomy (CEA). Ipsilateral clinical symptoms and duplex measurements were recorded. Patients could be asymptomatic (23.5%) or symptomatic with stroke (26.5%), transient ischemic attack (TIA) (36.1%), or amaurosis fugax (AFX) (13.9%). Plaques were stained and semi-quantitatively analyzed for the presence of macrophages, smooth muscle cells, collagen, calcifications, and thrombus. Plaques were categorized in three phenotypes by their overall presentation and the amount of fat. In addition, plaque matrix metalloproteinase (MMP) activity and cytokines expressions were measured. RESULTS: Fibrous, fibro-atheromatous, and atheromatous plaques were observed in 30.2%, 35.6%, and 34.2%, respectively. Atheromatous plaques were more prevalent in patients with stroke and TIA compared with asymptomatic patients or patients with AFX (P = .001). Collagen staining was less evident in patients with TIA and stroke compared with asymptomatic patients or patients with AFX (P < .001). Plaques of patients with TIA and stroke showed significantly higher activity levels of MMP-8 and MMP-9 and higher levels of interleukin-8 compared with asymptomatic and AFX patients. CONCLUSION: Plaque phenotype of patients with TIA is comparable to that of patients with stroke; whereas, the plaque phenotype of patients with AFX resembles the plaque phenotype of asymptomatic patients. Follow-up studies should be encouraged to determine whether plaque characteristics visualized by imaging techniques might help to identify patients most likely to benefit from CEA.
Authors: Monica Sigovan; Clément Bidet; Sébastien Bros; Loic Boussel; Laura Mechtouff; Philip M Robson; Zahi A Fayad; Antoine Millon; Philippe Douek Journal: Magn Reson Imaging Date: 2017-06-16 Impact factor: 2.546
Authors: Matthew R Alexander; Christopher W Moehle; Jason L Johnson; Zhengyu Yang; Jae K Lee; Christopher L Jackson; Gary K Owens Journal: J Clin Invest Date: 2011-12-27 Impact factor: 14.808
Authors: Zhu Chen; Marina Ichetovkin; Marc Kurtz; Emanuel Zycband; Douglas Kawka; John Woods; Xuanmin He; Andrew S Plump; Eric Hailman Journal: Lipids Health Dis Date: 2010-06-11 Impact factor: 3.876
Authors: Alexandra A J de Rotte; Wouter Koning; Anne G den Hartog; Sandra M Bovens; Jaco J M Zwanenburg; Dennis W J Klomp; Gerard Pasterkamp; Frans L Moll; Peter R Luijten; Gert Jan de Borst; Jeroen Hendrikse Journal: J Cereb Blood Flow Metab Date: 2014-07-30 Impact factor: 6.200
Authors: Dominic Pj Howard; Guus W van Lammeren; Peter M Rothwell; Jessica N Redgrave; Frans L Moll; Jean-Paul Pm de Vries; Dominique Pv de Kleijn; Hester M den Ruijter; Gert Jan de Borst; Gerard Pasterkamp Journal: Stroke Date: 2014-12-04 Impact factor: 7.914
Authors: N P E Kadoglou; P Moustardas; A Kapelouzou; M Katsimpoulas; A Giagini; E Dede; N Kostomitsopoulos; P E Karayannacos; A Kostakis; C D Liapis Journal: Eur J Histochem Date: 2013-03-25 Impact factor: 3.188
Authors: Guus W van Lammeren; Frans L Moll; Gert Jan De Borst; Dominique P V de Kleijn; Jean-Paul P M de Vries; Gerard Pasterkamp Journal: Curr Cardiol Rev Date: 2011-02